<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02709356</url>
  </required_header>
  <id_info>
    <org_study_id>2016-547</org_study_id>
    <nct_id>NCT02709356</nct_id>
  </id_info>
  <brief_title>Medium Chain Triglycerides and Brain Metabolism in Alzheimer's Disease</brief_title>
  <acronym>MCT-MA</acronym>
  <official_title>Proof of Concepts: Can a Supplement Ketogenic Based MCT Oil Increases Cerebral Capture Ketones in People With Alzheimer's Disease?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation Vitae</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate and compare the changes in brain ketone and glucose uptake after taking two
      different MCT oil emulsions (60-40 oil or C8 oil) for one month, in a group of people with
      Alzheimer's disease and a control group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Based on a PET/MRI protocol, the aim of this study is to evaluate and compare the response to
      the dietary supplementation of two different MCT oils (60% C10 + 40% C8 or 100 % C8) in two
      groups, patients with Alzheimer's disease and healthy elderly people (N=10/group). After a
      baseline evaluation, participant will test one of the supplements during two successive
      periods of one month; each period of time ending with 18F-FDG and 11C-acetoacetate PET scans.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification of brain glucose uptake</measure>
    <time_frame>1-month</time_frame>
    <description>Brain glucose uptake (umol/100g/min) using 18-FDG PET scan</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantification of brain acetoacetate uptake</measure>
    <time_frame>1-month</time_frame>
    <description>Brain acetoacetate uptake (umol/100g/min) using 11C-AcAc PET scan</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Alzheimer's Disease</condition>
  <arm_group>
    <arm_group_label>Alzheimer's disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with mild Alzheimer's disease.
1-month of 60-40 MCT oil and 1-month of C8 MCT oil (order of the two intervention are randomized)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy elderly people
1-month of 60-40 MCT oil and 1-month of C8 MCT oil (order of the two intervention are randomized)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>1-month of 60-40 MCT oil</intervention_name>
    <description>1-month supplementation of 30 g MCT oil (60% C10 + 40% C8)/day</description>
    <arm_group_label>Alzheimer's disease</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>1-month of C8 MCT oil</intervention_name>
    <description>1-month supplementation of 30 g MCT oil (100% C8)/day (1-month of C8 MCT oïl)</description>
    <arm_group_label>Alzheimer's disease</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Good general health for Control group

          -  Diagnosis of Alzheimer's disease (NINCDS-ADRDA criteria) for AD group

        Exclusion Criteria:

          -  Depression

          -  Medical or psychiatric conditions that could interfere with study participation

          -  Fasting plasma glucose ≥7.0 mM (diabetes or prediabetes)

          -  Already on MCT supplementation

          -  Clinically-significant gastrointestinal disease/conditions

          -  Clinically-significant liver disease/dysfunction

          -  Clinically-significant renal disease/dysfunction

          -  Clinically-significant cardiac disease/conditions

          -  Hypertension

          -  Uncontrolled dyslipidaemia

          -  Vitamin B12 deficiency

          -  Structured physical activity (more than 3 times/week)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Cunnane, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS) - Université de Sherbrooke</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melanie Fortier, MSc</last_name>
    <phone>819-780-2220</phone>
    <phone_ext>45252</phone_ext>
    <email>Melanie.Fortier2@USherbrooke.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christian-Alexandre Castellano, PhD</last_name>
    <phone>819-780-2220</phone>
    <phone_ext>45623</phone_ext>
    <email>Alexandre.Castellano@USherbrooke.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS)</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1H4C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Fortier, MSc</last_name>
      <phone>819-780-2220</phone>
      <phone_ext>45252</phone_ext>
      <email>Melanie.Fortier2@USherbrooke.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2016</study_first_submitted>
  <study_first_submitted_qc>March 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2016</study_first_posted>
  <last_update_submitted>December 19, 2017</last_update_submitted>
  <last_update_submitted_qc>December 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

